Status:
COMPLETED
Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor
Lead Sponsor:
Muhammad Aamir Latif
Conditions:
Labor
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
This study was planned to fill the gaps regarding the effectiveness of phloroglucinol on the duration of active phase of labor.
Detailed Description
In today's era, the focus has shifted from a "wait and watch" policy to "active intervention sooner than later" to enhance better labor outcomes. Using an ideal antispasmodic drug would help achieve a...
Eligibility Criteria
Inclusion
- Pregnant women aged between 18-35 years
- Period of gestation above 37 weeks.
Exclusion
- Women with cephalopelvic disproportion
- Double scare uterus
- Fetal distress
- Life threatening bleeding
- Eclampsia
- History of heart disease
- Known allergy to phloroglucinol
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT07184099
Start Date
January 1 2025
End Date
June 30 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined Military Hospital
Attock, Punjab Province, Pakistan, 43100